Summit Global Investments United Therapeutics Corp Transaction History
Summit Global Investments
- $1.57 Billion
- Q3 2024
A detailed history of Summit Global Investments transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Global Investments holds 49,999 shares of UTHR stock, worth $18.2 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
49,999
Previous 53,671
6.84%
Holding current value
$18.2 Million
Previous $17.1 Million
4.8%
% of portfolio
1.14%
Previous 1.15%
Shares
8 transactions
Others Institutions Holding UTHR
# of Institutions
667Shares Held
42.7MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.99 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.6 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.15 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$813 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...